AREV Life Sciences Global Corp
CNSX:AREV
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.09
0.09
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of AREV.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| ZA |
W
|
Woolworths Holdings Ltd
JSE:WHL
|
|
| US |
A
|
Archer-Daniels-Midland Co
XETRA:ADM
|
|
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
|
| IE |
|
Kerry Group PLC
ISEQ:KRZ
|
|
| CN |
|
Angel Yeast Co Ltd
SSE:600298
|
|
| JP |
|
Nissin Foods Holdings Co Ltd
TSE:2897
|
|
| KR |
|
CJ Corp
KRX:001040
|
|
| CN |
|
By-health Co Ltd
SZSE:300146
|
|
| UK |
|
Tate & Lyle PLC
LSE:TATE
|
|
| TH |
T
|
Thai President Foods PCL
SET:TFMAMA
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
AREV Life Sciences Global Corp
Balance Sheet Decomposition
AREV Life Sciences Global Corp
| Current Assets | 68.8k |
| Cash & Short-Term Investments | 1.8k |
| Receivables | 55.7k |
| Other Current Assets | 11.3k |
| Non-Current Assets | 144.5k |
| PP&E | 144.5k |
| Current Liabilities | 1.4m |
| Accounts Payable | 792.1k |
| Accrued Liabilities | 18k |
| Short-Term Debt | 122.1k |
| Other Current Liabilities | 444.2k |
Free Cash Flow Analysis
AREV Life Sciences Global Corp
| CAD | |
| Free Cash Flow | CAD |
Earnings Waterfall
AREV Life Sciences Global Corp
|
Revenue
|
0
CAD
|
|
Operating Expenses
|
-313.5k
CAD
|
|
Operating Income
|
-313.5k
CAD
|
|
Other Expenses
|
-5.6k
CAD
|
|
Net Income
|
-319.1k
CAD
|
AREV Profitability Score
Profitability Due Diligence
AREV Life Sciences Global Corp's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
AREV Life Sciences Global Corp's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
AREV Solvency Score
Solvency Due Diligence
AREV Life Sciences Global Corp's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Score
AREV Life Sciences Global Corp's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AREV Price Targets Summary
AREV Life Sciences Global Corp
Dividends
Current shareholder yield for AREV is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?